Author | Ankur Gupta, MD

Lewis Medical office

1695 MERRICK AVE

Articles

Evaluating cardiovascular risk in rheumatoid arthritis

There have been significant advances in the management of rheumatologic disorders with the availability of newer disease-modifying drugs and biologic agents. However, cardiovascular disease (CVD) morbidity and mortality remain significantly increased in patients with rheumatologic disorders, especially rheumatoid arthritis (RA)1-4 and systemic lupus erythematosus (SLE).